BCRX · Biocryst Pharmaceuticals Inc · Congressional Trades
Market Cap
$2.33B
Shares
255.54M
Transactions in this listed security by members of the U.S. Congress, disclosed under the STOCK Act. Lawmakers must report trades within 45 days, so the filing date can lag the trade itself.
| Date | Member | Position | Type | Owner | Amount | Filed | Lag |
|---|---|---|---|---|---|---|---|
| 2025-11-13 | Gilbert Cisneros | Representative | Buy BioCryst Pharmaceuticals, Inc. - Common Stock (BCRX) | — | $1K - $15K | 2025-12-15 | 32d |
| 2023-10-16 | Josh Gottheimer | Representative | Buy ST · BioCryst Pharmaceuticals, Inc. (BCRX) | JT Morgan Stanley - Select UMA Account # 1 | $1K - $15K | 2023-11-11 | 26d |
| 2023-09-15 | Josh Gottheimer | Representative | Sell ST · BioCryst Pharmaceuticals, Inc. (BCRX) | JT Morgan Stanley - Select UMA Account # 1 | $1K - $15K | 2023-10-15 | 30d |
| 2022-08-11 | Josh Gottheimer | Representative | Buy ST · BioCryst Pharmaceuticals, Inc. (BCRX) | JT Morgan Stanley - Select UMA Account # 1 | $1K - $15K | 2022-09-16 | 36d |
Showing 1–4 of 4 trades
Key facts
CIK
882796
CUSIP
09058V103
13F (30d)
208 filings
206 filers
Visit website
Investor relations